HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

"Bath Salts" Crackdown Goes Forward

You may also be interested in...



Bath Salts Industry Battles Negative Press, Public Misconceptions

The San Francisco Bath Salts Company, among other bath product manufacturers, is working to distance legitimate bath-salt makers from the dangerous synthetic drug known as “bath salts.” Confusion among consumers and unfavorable media attention has negatively impacted sales for industry members.

Cocaine-Like Drugs Masquerading As “Bath Salts” Have Regulators' Attention

By prominently featuring the words “bath salts” on product labeling, drugs with effects similar to those of cocaine and ecstasy have been selling off regulators' radar, but authorities are now starting to take action.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017456

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel